EpiEndo’s Founder, Fridrik Runar Gardarsson and Finnur Fridrik Einarsson (COO) will represent EpiEndo at the RESI conference in Boston on the 11th of September.

We are pleased to announce that we have successfully closed our 4th seed round of 2 million Euros. The round was led by a ABC Venture ehf.

EpiEndo’s CEO, Fredrik Lehmann will represent EpiEndo at Nordic Life Science Days.

EpiEndo welcomes Jennifer Kricker, PhD to the team.

EpiEndo has been nominated for the Nordic Life Science Business Class and Deligates choice Awards.

EpiEndo is proud to introduce new external advisers to our Scientific Advisory Board (SAB) and welcome Professors Peter Barnes, Dave Singh and Carl Persson to our team.

EpiEndo is pleased to announce that we have successfully closed a financing round of ISK 110 million (800.000 EUR).

EpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo.

EpiEndo Pharmaceuticals has signed a grant agreement today with the Icelandic Technology Development Fund.